Proteomics And Genomics Are Forcing A Re-look At Test Validation Protocol
This article was originally published in The Gray Sheet
Executive Summary
Test developers might need to adjust their approach to assay validation to facilitate adoption of some up-and-coming diagnostic technologies, several speakers suggested at an American Association of Clinical Chemistry meeting Oct. 25 in Washington, D.C